Study identity card

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥ 18 Years of Age to <50 Years of Age

United Kingdom
Share
  • Disease: Monkeypox virus infection
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional
  • Study aim: To assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants
  • Number of participants enrolled: 351
  • Study enrolling from to

Study Data

  • Adults
  • General population
  • Monkeypox virus
  • Monkeypox virus infection
  • Vaccination
  • Pharmacological intervention
  • mRNA-1769

Other information

Funders:

  • ModernaTX, Inc.

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to